MAPK and PI3K pathways are both downstream targets of EGFR activation [124], and in relation to its link to breast cancer, over expression of the EGFR in MCF-7 cells directly leads to a cancerous phenotype and one that is estrogen independent [125]. The gene discussed is EGFR; the disease is breast cancer.